Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on May 15, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders approved the Amended and Restated 2023 Omnibus Incentive Plan at the May 14, 2026 annual meeting.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Shareholders approved the Amended and Restated 2023 Omnibus Incentive Plan at the May 14, 2026 annual meeting
- Plan authorizes equity and other incentive awards for employees, directors, and consultants
- Our People & Culture Committee receives authority to approve awards
- Expanded incentive flexibility could affect future share dilution and compensation expense
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Shareholder turnout 81.29%, with 62,134,133 of 76,437,917 eligible shares voting
- All six directors elected to one-year terms, though Edward Pesicka received the lowest support at 48,760,777 votes
- KPMG ratified as independent auditor for fiscal 2026, with 61,255,312 votes in favor
- Executive compensation advisory vote passed with 48,137,834 votes for and 4,098,288 against
- Amended and Restated 2023 Omnibus Incentive Plan approved, supporting continued equity-based compensation authorization
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.